Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-563-3424
Dr. Davies is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 2004 - 2007
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 2001 - 2004
McGovern Medical School at UTHealthClass of 2001
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2027
GA State Medical License 2023 - 2027
TN State Medical License 2023 - 2027
LA State Medical License 2023 - 2026
OK State Medical License 2020 - 2026
WA State Medical License 2023 - 2026
American Board of Internal Medicine Medical Oncology- Join now to see all
Clinical Trials
- An Open-Label Phase II Study of the Combination of GSK2118436 and GSK1120212 in Patients With Metastatic Melanoma Which is Refractory or Resistant to BRAF Inhibitor Start of enrollment: 2012 Sep 01
- Testing the Addition of Navitoclax to the Combination of Dabrafenib and Trametinib in People Who Have BRAF Mutant Melanoma Start of enrollment: 2014 Mar 24
- CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases Start of enrollment: 2014 Aug 12
Publications & Presentations
PubMed
- Retraction Note: Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN.Dimpy Koul, Ranjani Parthasarathy, Ruijun Shen, Michael A Davies, Samar A Jasser
Oncogene. 2025-05-01 - Unveiling Common Transcriptomic Features between Melanoma Brain Metastases and Neurodegenerative Diseases.Irene Soler-Sáez, Alcida Karz, Marta R Hidalgo, Borja Gómez-Cabañes, Adolfo López-Cerdán
The Journal of Investigative Dermatology. 2025-05-01 - Improved Survival and Prognostication in Melanoma Patients With Brain Metastases: An Update of the Melanoma Graded Prognostic Assessment.Paul W Sperduto, Kathryn E Marqueen, Enoch Chang, Jing Li, Michael A Davies
Journal of Clinical Oncology. 2025-04-17
Journal Articles
- Author Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaJanice N Cormier, Ehab Hanna, Padmanee Sharma, Jennifer A Wargo, Isabella C Glitza, Sapna P Patel, Adi Diab, Jeffrey E Lee, Richard Royal, Randal Weber, Patrick Hwu, J..., Nature
- Publisher Correction: Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaScott Woodman, Alexander J Lazar, Michael A Davies, Neil Gross, Sapna P Patel, Isabella C Glitza, Ehab Hanna, Stephen Y Lai, Richard Ehlers, Amy Hessel, Padmanee Sharm..., Nature
- Neoadjuvant Immune Checkpoint Blockade in High-Risk Resectable MelanomaRichard Royal, Alexander J Lazar, Adi Diab, Sapna P Patel, Jeffrey E Lee, Padmanee Sharma, Patrick Hwu, Randal Weber, Jeffrey Gershenwald, Carol Lewis, Richard Ehlers,..., Nature
- Join now to see all
Press Mentions
The 'Carter Effect': How the Former President Gave Cancer Patients HopeDecember 29th, 2024- Physician-Scientist Focused on Improving Brain Metastases TreatmentFebruary 17th, 2023
- New Cell-Based Therapy for Melanoma Is More Effective Than Existing Treatment, Trial SaysSeptember 10th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
